NCT00720109 2020-04-13
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Phase 2/3 Completed
Clinical Trials
1 trialsPhase 2/3 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × hydrocortisone hemisuccinate × Clear all